📢 Introducing Automata's first advisory board 📢 We're proud to announce the appointment of our inaugural advisory board, featuring esteemed leaders from the health and life sciences industry. They will advise Automata’s board and senior leadership team on commercialisation strategy and provide key industry insight and guidance in each of their target subsectors. The board includes senior leaders from various sectors, including pharmaceuticals, healthcare, regulatory affairs, scientific research, and international trade, spanning private and public domains. Together we are working towards automation technologies being accessible to all laboratories, speeding up the development and delivery of life-changing treatments to patients. Read our press release here ➡️ bit.ly/4d7k8tX #BioTech #Healthcare #PressRelease
Automata
Software Development
London, England 13,053 followers
Automata is a global biotech company providing robotic automation solutions to the life sciences industry.
About us
Automata was founded with a clear aim: to unlock human potential with automation. Through our collaboration with some of the world’s leading pathology labs, we’ve developed the most comprehensive lab automation platform on the market. By simplifying environments and empowering people, Automata enables labs to scale with precision and creates new opportunities for scientists to accelerate innovation.
- Website
-
https://automata.tech/
External link for Automata
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Lab Automation, BioTech, Workflow Automation, Healthcare, Life Sciences, and Software
Locations
-
Primary
10 White Lion Street
London, England N1 9PD, GB
-
124 East Road
London, N1 6FB, GB
-
222 Third Street
Cambridge, Massachusetts 02142, US
Employees at Automata
-
Kurt Kaltenegger
Group Vice President / Head of ABB Technology Ventures (ATV)
-
Brian Macauley
Automata | Platform builder | Technologist | AWS | DevOps | Getting stuff done!
-
Joe Stringer
Health & Life sciences tech / Growth impact investor / NED & Exec Chair / Board advisor
-
Daniel S.
Director of LINQ Platform at Automata
Updates
-
Lab automation can enhance cancer genomics sequencing by: ✅ Improving data quality and accessibility Tools like LINQ can collect and contextualise extensive data, facilitating reproducible experiments. ✅ Removing bottlenecks Automating labour-intensive steps like sample preparation reduces human error and frees up researchers for more valuable tasks. ✅ Facilitating scale Automation allows for large-scale experiments, increasing efficiency and throughput and reducing costs. Check out our article below to learn more about the impact of lab automation in cancer genomics ⬇️ #Cancer #Genomics #LabAutomation
-
Automata reposted this
Elevate your lab's efficiency and precision! Discover the transformative power of automation in this insightful white paper, sponsored by Automata. From reducing errors to speeding up processes, this is your guide to the future of laboratory work. Don't miss out – download now and revolutionize your lab operations today! Read the White Paper 👉 https://lnkd.in/eDTicbsY #LabInnovation #Automation #CRO #WhitePaper
-
-
The wonderful Joao Bessa Pereira will be hosting a session at Lab Manager's Automation Digital Summit this Thursday to discuss the future of lab automation software 👏 He'll discuss the differences between lab automation scheduling engines and introduce a new hybrid approach: a dynamic replanning scheduler. This innovative approach to scheduling enables batch parallelisation, real-time error handling, dynamic rerouting, and deadlock prevention to improve data quality and streamline processes. 🗓 18th July ⏰ 11am (EDT) / 4pm (BST) 📍 Online Register via the link in the post below ⬇
🚨 Less Than a Week Left! 🚨 The Automation Digital Summit is happening on July 17-18! Join top industry leaders and transform your lab's future with insights from: 🔹 Frances Slater PhD & Kinnari Watson PhD from Opentrons Labworks Inc. 🔹 Mike Sommers from Roche 🔹 Joao Bessa Pereira from Automata 🔹 Carleen Klumpp-Thomas from the National Center for Advancing Translational Sciences (NCATS) 📅 Date: July 17-18 📍 Online Event ⏳ Time is running out fast! Secure your spot today and stay ahead in the world of lab automation. 👏 Sponsored by PolyScience, Metrohm, Opentrons Labworks Inc., Automata, and Zaber Technologies. Register now and make sure you don't miss this game-changing event! 🌟 https://lnkd.in/eVnNN6hH #LabAutomation #DigitalSummit #FutureOfLabs #Innovation #ScienceAndTech
Automation Digital Summit
summit.labmanager.com
-
In honour of her six-year Automa-versary, this week we're spending one minute with Karian L., our Head of People 🎖️ Here are some things - other than Karian joining Automata - that happened in 2018 in the UK: 💷 Paper £10 notes ceased to be legal tender 🧴 Microbeads in cosmetics were banned ⚽️ Croatia beat England in the World Cup Semi-Final 🍫 The sugar tax came into effect If you fancy joining Team Automata, head here ➡️ bit.ly/3lnq7Be #Culture #Hiring #People
-
Are the manual processes in your lab getting you down? 😑 Build your current workflows with our Lab Configurator to see how LINQ Bench can provide your lab with end-to-end automation. Have a go ➡️ bit.ly/467NxBa #LabAutomation #LINQ #AR
-
-
Earlier this year, Professor Dame Sue Hill, England’s Chief Scientific Officer, and Richard Meddings, NHS England Chair, visited the UK’s first robotic genomic testing facility for cancer patients at The Royal Marsden NHS Foundation Trust’s Sharjah Clinical Genomics Laboratory 👏 Our partnership with this world-leading cancer hospital pioneers automation to increase patient access to a wider range of state-of-the-art tests. By implementing Automata’s automation platform, LINQ, the lab's genomics testing capacity is doubled, providing faster access to crucial tests for cancer diagnosis, risk assessment, and personalised treatment. #BioTech #Genomics #NHS
-
-
Lilly W., Co-Founder and CEO of Synteny, discusses the innovative automation processes revolutionising T-cell research in this clip from our recent panel discussion, 'Advances in Bio-Automation'. Synteny's team has scaled experiments without the need for wells by creating unstructured pools of T-cell receptor sequences and using barcoding and sequencing. Watch the full panel discussion here 👉 bit.ly/3KYKSjn #AI #BioTech #LabAutomation
-
Enzyme-linked immunosorbent assay (ELISA) is a fundamental technique in immunology, commonly used to quantify antibodies, antigens, proteins, and glycoproteins in biological samples 💉 While manual execution of ELISA is still common in many research and diagnostic labs, it is prone to human error, leading to inconsistent results. Our blog post shares frequent mistakes made during manual ELISA and highlights how automation can mitigate these issues ⬇️ #BioTech #ELISA #Immunology
Common errors in manual ELISA and how automation can help
https://automata.tech
-
This is why Fane Mensah, MSc, PhD, Alice Tome-Fernandez, Adam Morris, Richard Grochmal, Karian L. and Teresa Bartaseviciute chose to work for Automata. Fancy joining us? 👉 bit.ly/3lnq7Be #Culture #Hiring #People